The application of laferon in a combined therapy of purulent cholangitis
Kopchak, V.M.; Todurov, I.M.; Stasenko, A.A.; Dronov, A.I.; Khomiak, I.V.; Serdiuk, V.P.; Gusev, A.V.
Klinichna Khirurhiia 4: 27-29
2002
ISSN/ISBN: 0023-2130 PMID: 12145854 Document Number: 548853
Results of treatment of 160 patients, operated on for nontumoral biliary ducts impassibility, complicated by purulent cholangitis, were analyzed. In 60 patients intraoperatively and after the operation in complex of treatment laferon solution was injected into biliary ducts in dosage 500,000--1 million IU a day, permitting to reduce the frequency of the postoperative complications occurrence from 62.2 to 36% and of postoperative mortality--from 13 to 6%. Regional immune therapy using laferon stimulates the factors of organism inflammatory reaction and hepatocytes functional state restoration.